Sight Sciences, Inc. (SGHT)
| Previous close | 8.14 |
| Open | 8.30 |
| Bid | 8.36 x 800 |
| Ask | 8.39 x 900 |
| Day's range | 8.16 - 8.58 |
| 52-week range | 6.25 - 42.57 |
| Volume | |
| Avg. volume | 372,126 |
| Market cap | 398.093M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -3.29 |
| Earnings date | 10 Nov 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 17.00 |
- GlobeNewswire
Sight Sciences Reports First Quarter 2022 Financial Results
MENLO PARK, Calif., May 10, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, today reported financial results for the quarter ended March 31, 2022. Recent Business Highlights Generated first quarter 2022 total revenue of $14.9 million, an increase of 72% compared to the prior year periodIncreased the number of facilities ordering the OMNI® Surgical System fr
- Simply Wall St.
What You Need To Know About Sight Sciences, Inc.'s (NASDAQ:SGHT) Investor Composition
A look at the shareholders of Sight Sciences, Inc. ( NASDAQ:SGHT ) can tell us which group is most powerful. Large...
- GlobeNewswire
Sight Sciences to Present at the Upcoming Bank of America Healthcare Conference
MENLO PARK, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, today announced plans to participate in the upcoming Bank of America Healthcare Conference. Sight Sciences’ management is scheduled to present Thursday, May 12, 2022, at 9:20am PT. Interested parties may access a live and archived webcast of the presentation on the “Investors” sect
